Mounjaro Plans: Matching the Right Approach to Your Situation

The decision you're probably trying to make, and why it's not just about dose

Most people who land on this topic have already done some reading. They know Mounjaro exists, they've seen the trial headlines, and now they're trying to work out whether the shape of treatment (the pace of dose changes, what support is included, what happens if they plateau) is something they can commit to. That's a reasonable thing to want to understand before you start.

The dose ladder runs from 2.5 mg to 15 mg, in 2.5 mg steps. The opening dose exists to settle your system gently; the NHS medicines page for tirzepatide confirms it's a tolerability measure, not a therapeutic target. Steps upward typically happen every four weeks, guided by the prescriber based on how you're getting on, not on a fixed timetable. Some people stay at an intermediate dose for longer; some reach 15 mg comfortably; some find a middle strength is where benefit and tolerability balance. There is no universally right answer, which is exactly why the plan can't be handed over at checkout.

Beyond the dose, the plan requires genuine lifestyle change alongside it. Reduced calorie intake and increased physical activity are part of the licensed use, not optional extras. Mounjaro reduces appetite substantially, which makes it easier to sustain a calorie deficit, but the habit-building that happens in parallel is what tends to support results in the longer term. Your prescriber will talk through what's realistic for you.

Which Mounjaro plan structures exist, and what private treatment looks like in practice

In a private setting, you'll typically pay per pen (each pen holds four weekly doses) and have treatment re-reviewed before each repeat. There's no automatic continuation, a repeat prescription is issued after a fresh clinical review that checks your weight trend, any side effects, and whether ongoing treatment remains appropriate. That model differs from a subscription-style service where medicine ships without review, and it matters: dose increases in particular should be evidence-led, not assumed.

Some providers bundle consultation, prescription and delivery into one price; others charge for each separately. If you're comparing options, it's worth working out the total cost including aftercare support. The full picture on what Mounjaro typically costs in the UK covers the range in more detail, including what the September 2025 Eli Lilly list-price increase means for private market pricing.

At nume, there are no subscriptions and no auto-renewals. Every repeat order is looked at by a GPhC-registered Independent Prescriber before it's approved. The consultation is free, delivery is free, and the prescription fee is included, one price that covers everything. You can read about payment plan options if spreading the cost matters to your planning.

For people who want to think through the full weight-loss journey alongside treatment, the Mounjaro weight-loss plan page goes into the lifestyle element in more depth.

Eligibility: the factors that shape whether you're a candidate

The licensed criteria are: adults, BMI 30 or above, or 27 or above if you have at least one weight-related condition such as high blood pressure, raised cholesterol, prediabetes, type 2 diabetes, or obstructive sleep apnoea. Lower BMI thresholds may apply depending on ethnic background, in line with UK clinical guidance. But meeting the headline numbers is only part of the picture.

Your prescriber will also consider your full health history. Mounjaro isn't recommended in pregnancy, during breastfeeding, or if you're actively trying to conceive. People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 should not take it. A past episode of pancreatitis, or certain gastrointestinal conditions, will prompt careful discussion before treatment is approved. These aren't bureaucratic hurdles, they reflect real clinical considerations that only a prescriber working through your case can properly weigh.

It's also worth knowing that NHS access to Mounjaro is being phased in gradually through strict cohort criteria under NICE TA1026. If you don't currently meet the NHS thresholds, or simply don't want to wait, private treatment through a regulated pharmacy is the alternative. More background on the medicine itself is on the Mounjaro information page, and if you want to explore how tirzepatide fits the broader treatment landscape, the tirzepatide overview sets out the clinical context clearly.

Matching a plan to your actual situation

If you've been on Mounjaro before and stopped (whether because of cost, a supply issue, or a break for another reason) restarting isn't necessarily straightforward. The prescriber will want to understand the gap, your current weight relative to where you started, and whether any dose adjustment is appropriate. The Mounjaro reset page covers exactly this ground.

Equally, if you're weighing Mounjaro against other treatment routes, the weight-loss treatment overview is a useful place to sit with the comparison before you decide. The decision doesn't have to be made in a hurry. Honestly, most people who've been trying to lose weight for some time feel a mix of hope and wariness at this point, hope that this time something might genuinely shift things, and a reasonable caution about whether it's the right step. Both are sensible. A conversation with a prescriber who's reviewed your full picture is the most useful thing you can do from here.

When you're ready, speak to our prescribers, the consultation is free, there's no obligation, and the same-day review means you'll have a clinical answer quickly.